Concepedia
Publication | Open Access
Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma
57
Citations
13
References
2022
Year
ClinicalTrials.gov Identifier: NCT03354884.
Page 1